Evidence map›Paper›PMID 36328299›Full record

ArticleThe American journal of pathology2023

Distinct Phenotypic Consequences of Pathogenic Mutants Associated with Late-Onset Retinal Degeneration.

Lei Xu, William N Ruddick, Susan N Bolch, Mikael Klingeborn, Frank M Dyka, Manoj M Kulkarni, Chiab P Simpson, William A Beltran, Catherine Bowes Rickman, W Clay Smith and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Lei XuDepartment of Ophthalmology, College of Medicine, University of Florida, Gainesville, Florida.
William N RuddickDepartment of Ophthalmology, College of Medicine, University of Florida, Gainesville, Florida.
Susan N BolchDepartment of Ophthalmology, College of Medicine, University of Florida, Gainesville, Florida.
Mikael KlingebornMcLaughlin Research Institute, Great Falls, Montana; Helen Wills Neuroscience Institute, Berkeley, California.
Frank M DykaDepartment of Ophthalmology, College of Medicine, University of Florida, Gainesville, Florida.
Manoj M KulkarniDivision of Experimental Retinal Therapies, Department of Clinical Sciences and Advanced Medicine, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Chiab P SimpsonDepartment of Ophthalmology, College of Medicine, University of Florida, Gainesville, Florida.
William A BeltranDepartment of Ophthalmology, Duke University Medical Center, Durham, North Carolina.
Catherine Bowes RickmanHelen Wills Neuroscience Institute, Berkeley, California; Department of Cell Biology, Duke University Medical Center, Durham, North Carolina.
W Clay SmithDepartment of Ophthalmology, College of Medicine, University of Florida, Gainesville, Florida.
Astra DinculescuDepartment of Ophthalmology, College of Medicine, University of Florida, Gainesville, Florida. Electronic address: astra@ufl.edu.
University of Florida · USDuke Medical Center · USDuke University · USMcLaughlin Research Institute · USUniversity of Pennsylvania · US

Funding

VISION RESEARCHP30EY005722 · NEI · DUKE UNIVERSITY · PI Vadim Y Arshavsky · 1985 to 2026
$19.3M
CLARIN 1 RETINAL FUNCTION AND THERAPEUTIC IMPLICATIONS FOR USH3R01EY026559 · NEI · UNIVERSITY OF FLORIDA · PI ASTRA DINCULESCU, Brian A Link · 2016 to 2026
$4.7M
RESEARCH TRAINING IN VISION SCIENCET32EY007132 · NEI · UNIVERSITY OF FLORIDA · PI W CLAY SMITH · 1991 to 2026
$3.8M
Complement factor H modulates lipoprotein clearance in AMDR01EY031748 · NEI · DUKE UNIVERSITY · PI BOWES RICKMAN, CATHERINE · 2020 to 2024
$2.8M
Generation and Characterization of Novel Large Animal Models of Usher Syndrome Type 3R21EY032575 · NEI · UNIVERSITY OF FLORIDA · PI DINCULESCU, ASTRA, MCCALL, MAUREEN A · 2022 to 2023
$436k
Core Equipment for Assessment of Ocular Disease in Animal ModelsS10OD028476 · OD · UNIVERSITY OF FLORIDA · PI SMITH, W CLAY · 2020 to 2020
$348k
NEI NIH HHS P30 EY005722NEI NIH HHS R01 EY026559NEI NIH HHS R01 EY031748NEI NIH HHS T32 EY007132NIH HHS S10 OD028476
6 · The paper itself

Abstract

A pathologic feature of late-onset retinal degeneration caused by the S163R mutation in C1q-tumor necrosis factor-5 (C1QTNF5) is the presence of unusually thick deposits between the retinal pigmented epithelium (RPE) and the vascular choroid, considered a hallmark of this disease. Following its specific expression in mouse RPE, the S163R mutant exhibits a reversed polarized distribution relative to the apically secreted wild-type C1QTNF5, and forms widespread, prominent deposits that gradually increase in size with aging. The current study shows that S163R deposits expand to a considerable thickness through a progressive increase in the basolateral RPE membrane, substantially raising the total RPE height, and enabling their clear imaging as a distinct hyporeflective layer by noninvasive optical coherence tomography in advanced age animals. This phenotype bears a striking resemblance to ocular pathology previously documented in patients harboring the S163R mutation. Therefore, a similar viral vector-based gene delivery approach was used to also investigate the behavior of P188T and G216C, two novel pathogenic C1QTNF5 mutants recently reported in patients for which histopathologic data are lacking. Both mutants primarily impacted the RPE/photoreceptor interface and did not generate basal laminar deposits. Distinct distribution patterns and phenotypic consequences of C1QTNF5 mutants were observed in vivo, which suggested that multiple pathobiological mechanisms contribute to RPE dysfunction and vision loss in this disorder.

Indexed as

Retinal DegenerationAnimalsHumansMiceMutationPhenotypeRetinal Pigment Epithelium

Identifiers

PMID36328299
PMCPMC10726427
OpenAlexW4307910493

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.